Viral Hepatitis Testing: Strategies for Assessing Laboratories
This toolkit is intended to assist health department viral hepatitis programs to assess viral hepatitis testing in laboratories operating in their jurisdictions.
This toolkit is intended to assist health department viral hepatitis programs to assess viral hepatitis testing in laboratories operating in their jurisdictions.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This flipbook provides basic information on active TB disease. The flipbook is in English and Marshallese. The resource can be used while working with patients and families from the Marshallese community.
This flipbook provides basic information on active TB disease. The resource can be used while working with patients and families from the Marshallese community.
This video presents a history of TB in Bethel, a region in southwestern Alaska. The video also highlights the importance of TB screening and treatment completion.
This document includes fast facts on heaptitis B and how B hepatitis B is the most common serious liver infection in the world. It is caused by the hepatitis B virus (HBV), which attacks liver cells and can lead to cirrhosis (scarring), liver failure, or liver cancer.
The liver is one of the body’s most important organs. It cleans toxins from the body and helps it digest food and absorb nutrients. The hepatitis B virus lives in the liver and can cause damage. It is important for people with hepatitis to understand their liver and how to protect it.
Liver Cancer Awareness Month Graphics for digital use.
This document discusses how an estimated 2.4 million people in the U.S. are living with hepatitis C infection, while up to 1.59 million people could be living with hepatitis B in the U.S. The need for expanded, standardized, and reliable viral hepatitis surveillance continues to impact public health efforts, resources, and response across the U.S. to this epidemic.